Anti-CD99 [10D2A10F9]

Absolute Antibody

Anti-CD99 [10D2A10F9]

9

The antibody specifically detected CD99 by Western blot analysis. The antibody 10D2A10F9 and the commercial antibody O13 were used to stain ovarian granulosa cell tumor and primitive neuroectodermal tumor. Results showed the antibody specificity is comparable to the commercial antibody. Further, the sensitivity of the antibody 10D2A10F9 was higher than the commercial antibody. The antibody and the commercially available antibody O13 were simultaneously detected on the normal tissue chip, indicating that the specificity of the antibody in normal tissue was equivalent to that of the commercially available antibody (CN113929783A).

Western Blot, ImmunoHistoChemistry

Research Use Only

Monoclonal

10D2A10F9

CD99

CD99 molecule (Xg blood group)

HBA71, MIC2, MIC2X, MIC2Y, MSK5X, CD99 antigen, E2 antigen, MIC2 (monoclonal antibody 12E7), T-cell surface glycoprotein E2, antigen identified by monoclonal 12E7, Y homolog, antigen identified by monoclonal antibodies 12E7, F21 and O13, cell surface antigen 12E7, cell surface antigen HBA-71, cell surface antigen O13, surface antigen MIC2

Human

IgG1

CD99 antigen

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques.

Human

-20°C,2°C to 8°C

12352203